Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not
Introduction
Our view of how the cell nucleus is spatially and functionally organized has changed dramatically since it has become possible to study the localization and kinetics of nuclear components in living cells. With the advent of probe and green fluorescent protein (GFP) technologies as well as live cell imaging methods, chromatin dynamics, RNA transport, and protein localization and kinetics have been extensively studied. These studies have revealed that chromatin can be highly dynamic (Gasser, 2002; Tumbar et al., 1999), that RNAs are transported throughout the interchromatin space (Dirks et al., 1999, Dirks et al., 2001; Politz et al., 1999), and that proteins involved in diverse nuclear processes are highly mobile (Chen et al., 2002; Dundr and Misteli, 2001; Houtsmuller et al., 1999; Leung and Lamond, 2002; Misteli et al., 1997; Snaar et al., 2000). Many nuclear proteins reside in nuclear compartments and, by tagging these proteins with GFP, the dynamic behavior of these compartments could be analyzed by time-lapse microscopy. Cajal bodies, for example, were shown to move in the nucleoplasm and occasionally were shown to fuse to form larger bodies and to split from larger bodies (Platani et al., 2000; Snaar et al., 2000). The functions of most nuclear compartments have not been completely resolved yet and this is particularly true for PML bodies. PML bodies, also referred to as ND10 (nuclear domain 10) or PODs (PML oncogenic domains), range in size from 0.2 to 1 μm and are present in 10–30 copies per nucleus. They fluctuate in size and number during the cell cycle (Everett et al., 1999).
Since the identification of Sp100 as a component of PML bodies (Szostecki et al., 1990), many other proteins have been found present in these compartments (Matera, 1999; Negorev and Maul, 2001). Because these proteins fulfill multiple biological functions, PML bodies have been implicated to play a role in various cellular processes including the control of chromatin or heterochromatin architecture (Seeler et al., 1998), regulation of apoptosis (Guo et al., 2000; Wang et al., 1998), transcription (LaMorte et al., 1998), MHC class I antigen presentation (Zheng et al., 1998), detection of foreign protein or protein–nucleic acid complexes and proteolytic degradation (Everett et al., 1997; Tsukamoto et al., 2000), antiviral defense (Ishov and Maul, 1996), and cell proliferation and tumor suppression (Salomoni and Pandolfi, 2002). It cannot be excluded, however, that the main or only function of PML bodies may be to regulate the recruitment and release of proteins in order to control their availability at nucleoplasmic sites other than PML bodies as suggested by Negorev and Maul (2001). In their view, PML bodies function as a nuclear depot (Maul, 1998). Essential for the assembly and stability of PML bodies are PML and its modification by the small ubiquitin-related protein SUMO-1 (Müller et al., 1998). Cells lacking PML or expressing PML–RARα and RARα–PML fusion proteins, as in acute promyelocytic leukemia cells, do not reveal PML bodies. Less well understood is the role of SUMO-1 modification in PML body assembly because studies using PML mutants that cannot be SUMO-modified provide contradictory results (Ishov et al., 1999; Müller et al., 1998). Therefore, SUMO modification has been proposed to be a control mechanism in the accumulation of proteins at PML bodies. For example, SUMO modification of PML proved essential for the recruitment of Daxx, a protein enriched in condensed chromatin, to PML bodies (Ishov et al., 1999). Also, other proteins, including CREB binding protein (CBP), Blooms (BLMs), and Sp100, do not localize at PML bodies in the absence of PML, though SUMO modification of PML does not seem to play a role in their recruitment. In contrast to PML, SUMO-1 modification of Sp100 does not appear to play a role in its deposition at PML bodies (Sternsdorf et al., 1997).
How proteins are recruited to PML bodies is still enigmatic but adaptor proteins and protein–protein interactions are assumed to be essential to this process. On the basis of their kinetic behavior, PML and Sp100 are suggested to play structural roles in PML bodies (Boisvert et al., 2001). Fluorescence recovery after photobleaching (FRAP) analysis of GFP–PML and GFP–Sp100 movement revealed that these chimeric proteins are immobile inside PML bodies (Boisvert et al., 2001). At the same time, another PML inhabitant, the transcription coactivator CBP, was shown to move rapidly into and out of these bodies. The observation that PML and Sp100 are immobile in PML bodies is in contradiction to the hypothesis that nuclear compartments are the reflection of steady-state association/dissociation of its residents with the nucleoplasm (Phair and Misteli, 2000). In fact, proteins that localize at diverse nuclear compartments were shown to exhibit rapid movements (Kruhlak et al., 2000; Phair and Misteli, 2000; Snaar et al., 2000).
We therefore reevaluate the kinetic behavior of PML, Sp100, and CBP and show that all three proteins are dynamic components of PML bodies. In addition, using time-lapse fluorescence microscopy, we show that PML bodies exhibit little movement in interphase cell nuclei but that Sp100 foci that do not contain PML exhibit more extended movement. The generally small-sized Sp100-containing foci appear to fuse with larger PML bodies but not to separate from them. These observations suggest that homooligomerization of Sp100 in the nucleoplasm can occur in the absence of PML and precede recruitment to PML bodies.
Section snippets
Cell culture
VH10 human primary fibroblasts and U2OS human osteosarcoma cells were cultured on 3.5-cm glass bottom petri dishes (Mattek, Ashland, MA) in DMEM without phenol red containing 1.0 mg/ml glucose, 10% fetal calf serum, 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin and buffered with 25 mM Hepes buffer to pH 7.2 (all from Invitrogen). Cells were maintained at 37 °C in a humidified 5% CO2 atmosphere.
Plasmid constructs and cell transfection
Full-length PML in an EGFP–C1 vector was a gift from Dr. A.G. Jochemsen (LUMC, Leiden).
Fusion proteins of PML, Sp100, and CBP with EYFP or ECFP localize to PML bodies
PML, Sp100, and CBP were fused at their amino terminus to EYFP and to ECFP and transiently transfected in VH10 fibroblasts and in U2OS cells. Before time-lapse experiments were started, the distribution of these chimeric proteins at PML bodies was confirmed by immunocytochemistry. EYFP– and ECFP–Sp100 and EYFP– and ECFP–PML were shown to localize at PML bodies in both cell lines. EYFP– and ECFP–CBP also localized at PML bodies, but generally at lower intensities, and the amount varied among
Acknowledgments
We thank Alt Zantema, Eric Kalkhoven, and A.G. Jochemsen for PML and CBP plasmids. This work was supported by the Dutch Scientific Organization NWO program “4D Imaging of Living Cells and Tissues”, Grant 901-34-144.
References (41)
- et al.
Movement of nuclear poly(A) throughout the interchromatin space in living cells
Curr. Biol.
(1999) - et al.
The role of PML in tumor suppression
Cell
(2002) - et al.
The nuclear dot protein Sp100, characterization of domains necessary for dimerization, subcellutar localization, and modification by small ubiquitin-like modifiers
J. Biol. Chem.
(1999) - et al.
Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA
J. Cell Biol.
(2000) - et al.
The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia body
J. Cell Biol.
(2001) - et al.
TBP dynamics in living human cells: constitutive association of TBP with mitotic chromosomes
Mol. Cell. Biol.
(2002) - et al.
Synthesis, processing, and transport of RNA within the three-dimensional context of the cell nucleus
Crit. Rev. Eukaryot. Gene Expr.
(1999) - et al.
Methods for visualizing RNA processing and transport pathways in living cells
Histochem. Cell Biol.
(2001) - et al.
Functional architecture in the cell nucleus
Biochem. J.
(2001) - et al.
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
EMBO J.
(1997)
Cell cycle regulation of PML modification and ND10 composition
J. Cell Sci.
Visualizing chromatin dynamics in interphase nuclei
Science
The function of PML in p53-dependent apoptosis
Nature Cell Biol.
Action of DNA repair endonuclease ERCC1/XPF in living cells
Science
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition
J. Cell Biol.
PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1
J. Cell Biol.
The mobility of the GFP–ASF splicing factor in live cells
J. Cell Biol.
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
Proc. Natl. Acad. Sci. USA
Chromatin components as part of a putative transcriptional repressing complex
Proc. Natl. Acad. Sci. USA
In vivo analysis of NHPX reveals a novel nucleolar localization pathway involving a transient accumulation in splicing speckles
J. Cell Biol.
Cited by (53)
PML Nuclear Body Biogenesis, Carcinogenesis, and Targeted Therapy
2020, Trends in CancerCitation Excerpt :It generates several isoforms [2] which can all contribute to the formation of PML nuclear bodies (NBs) [3], a membraneless super-assembled subnuclear organelle [4]. The PML protein, the main component of PML NBs, displays remarkable dynamic activities because it can translocate from the nucleoplasm to PML NBs or between PML NBs in the nuclear matrix [5]. Numerous reports have shown that PML NBs are involved in numerous cellular pathways including stem cell self-renewal, transcriptional regulation, DNA damage responses, cell proliferation, apoptosis, and viral infection defense [6–12].
Two stages of XRCC1 recruitment and two classes of XRCC1 foci formed in response to low level DNA damage induced by visible light, or stress triggered by heat shock
2016, DNA RepairCitation Excerpt :This prompted us to look further into possible links between this protein and the known nuclear bodies. Since it has been suggested before that XRCC1 might reside in PML nuclear bodies [44] and, on the other hand, it was shown that, in response to heat shock, PML NBs become disrupted and form multiple microfoci [45], we investigated the spatial positions of XRCC1 foci with respect to the structures containing Sp100, a major component of both large PML NBs and small, mobile micro-bodies formed in response to stress [46]. Prior to stress, in HeLa cells co-expressing GFP-Sp100 and RFP-XRCC1, Sp100 protein was distributed mainly between large and small nuclear bodies, but a mobile pool of this protein was also detectable.
Role of nuclear bodies in apoptosis signalling
2008, Biochimica et Biophysica Acta - Molecular Cell ResearchMacromolecular crowding and its potential impact on nuclear function
2008, Biochimica et Biophysica Acta - Molecular Cell ResearchChromatin movement visualized with photoactivable GFP-labeled histone H4
2008, DifferentiationTyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells
2007, Experimental Cell Research